Keyence vs Novo Nordisk
Vergleich der Marktkapitalisierung im Zeitverlauf
Keyence
$136.7B
Rang #124
Novo Nordisk
$143.8B
Rang #120
Marktkapitalisierung im Zeitverlauf
Wichtige Momente
- Keyence überholte Novo Nordisk bis 2005
- Novo Nordisk überholte Keyence bis 2007
Vergleich Jahr für Jahr
| Jahr | Keyence | Novo Nordisk | Spitzenreiter |
|---|---|---|---|
| 2026 | $136.7B | $143.8B | Novo Nordisk |
| 2025 | $91.7B | $152.9B | Novo Nordisk |
| 2024 | $103.7B | $285.3B | Novo Nordisk |
| 2023 | $99.2B | $315.6B | Novo Nordisk |
| 2022 | $81.7B | $209.4B | Novo Nordisk |
| 2021 | $114.3B | $161.6B | Novo Nordisk |
| 2020 | $91.4B | $92.0B | Novo Nordisk |
| 2019 | $60.3B | $81.6B | Novo Nordisk |
| 2018 | $43.5B | $61.4B | Novo Nordisk |
| 2017 | $49.2B | $67.2B | Novo Nordisk |
| 2016 | $31.2B | $49.6B | Novo Nordisk |
| 2015 | $26.0B | $75.8B | Novo Nordisk |
| 2014 | $20.8B | $48.6B | Novo Nordisk |
| 2013 | $17.4B | $36.5B | Novo Nordisk |
| 2012 | $9.2B | $33.0B | Novo Nordisk |
| 2011 | $6.5B | $23.3B | Novo Nordisk |
| 2010 | $8.2B | $43.8B | Novo Nordisk |
| 2009 | $6.7B | $22.7B | Novo Nordisk |
| 2008 | $5.2B | $9.1B | Novo Nordisk |
| 2007 | $7.9B | $22.1B | Novo Nordisk |
| 2006 | $9.2B | $7.7B | Keyence |
| 2005 | $9.5B | $5.7B | Keyence |
| 2004 | $5.4B | $9.4B | Novo Nordisk |
| 2003 | $5.3B | $7.5B | Novo Nordisk |
| 2002 | $4.8B | $6.2B | Novo Nordisk |
| 2001 | $5.1B | $10.3B | Novo Nordisk |